1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Slovenia Pharmaceuticals and Healthcare Report Q1 2016

Slovenia Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 80 pages

Includes 3 FREE quarterly updates

BMI View: Krka's exposure to Eastern European markets will continue to act as a drag on revenue growth.However, strong sales growth in Western Europe will mitigate the impact of revenue declines for the shortterm. We expect a continued focus on cost containment by European healthcare payers to moderate Krka'sgrowth outlook over the longer term, unless the company looks to geographically diversify its exposure.Headline Expenditure Projections? Pharmaceuticals: EUR675mn (USD896mn) in 2014 to EUR671mn (USD738mn) in 2015; -0.6% inlocal currency terms and -17.6% in US dollar terms.

Forecasts unchanged compared to previous quarter.

? Healthcare: EUR3.22bn (USD4.27bn) in 2014 to EUR3.23bn (USD3.55bn) in 2015; 0.3% in localcurrency terms and -16.8% in US dollar terms. Forecasts unchanged compared to previous quarter.

Table Of Contents

Slovenia Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Slovenia 2013-2019) 8
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovenia 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovenia 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019) 25
OTC Medicines Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovenia 2011-2019) 28
Pharmaceutical Trade Forecast 29
Table: Pharmaceutical Trade Data And Forecasts (Slovenia 2013-2019) 31
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovenia 2013-2019) 31
Industry Risk Reward Index 32
Central And Eastern Europe Risk/Reward Index - Q1 2016 32
Slovenia Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 42
Pricing Regime 42
Reimbursement Regime 44
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Slovenia 2009-2014) 51
Table: Healthcare Personnel (Slovenia 2009-2014) 51
Table: Healthcare Activity (Slovenia 2009-2014) 52
Research and Development 52
Clinical Trials 52
Epidemiology 53
Competitive Landscape 56
Research-Based Industry 56
Table: Table: Multinational Market Activity 56
Generic Drugmakers 57
Pharmaceutical Industry Developments 58
Company Profile 59
Krka 59
Lek (Novartis/Sandoz) 65
Demographic Forecast 69
Table: Population Headline Indicators (Slovenia 1990-2025) 70
Table: Key Population Ratios (Slovenia 1990-2025) 70
Table: Urban/Rural Population and Life Expectancy (Slovenia 1990-2025) 71
Table: Population By Age Group (Slovenia 1990-2025) 71
Table: Population By Age Group % (Slovenia 1990-2025) 72
Glossary 74
Methodology 76
Pharmaceutical Expenditure Forecast Model 76
Healthcare Expenditure Forecast Model 76
Notes On Methodology 77
Risk/Reward Index Methodology 78
Index Overview 79
Table: Pharmaceutical Risk/Reward Index Indicators 79
Indicator Weightings 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.